Chronic Lymphocytic Leukemia | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Chronic Lymphocytic Leukemia (Part 4)

published 3 weeks ago by Dr Neil Love

Proceedings from part 4 of a 4-part webinar series. Featuring perspectives from Drs Paul M Barr, Matthew S Davids and Kerry Rogers, including the following topics: Introduction (0:00) Available and emerging data with Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia (CLL) (0:53) Role of Bcl-2 inhibitors for CLL (26:46) Novel strategies under investigation for CLL — U2 regimen (umbralisib/ublituximab) and CAR (chimeric antigen receptor) T-cell therapy (50:17) CME information and select publications

more episodes from Research To Practice | Oncology Videos